drugset / Trial / NCT00690092
A Multi-center Study of Spherule-Derived Coccidioidin
RandomizedParallel-groupTriple-blindDiagnostic
Summary
Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Induration greater than or equal to 5 mm after 48 hours was considered positive for exposure to C. immitis.
Timeline
- Start
- 2005-05
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Spherule-derived coccidioidin | Unknown | 1.27 ug | Other |